Vivos Therapeutics (VVOS) Common Equity (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Common Equity of -$1.1 million for Q1 2026, down 125.82% year-over-year from $4.4 million in Q1 2025, and up 26.58% quarter-over-quarter from -$1.5 million in Q4 2025.
Vivos Therapeutics (VVOS) Common Equity (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Common Equity for 8 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 125.82% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$1.1 million (down 125.82% YoY), while the FY2025 annual figure was -$1.5 million, down 119.49% from the prior year.
- Common Equity rose to -$1.1 million in Q1 2026 per VVOS's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Common Equity topped out at $21.0 million in Q1 2022 and bottomed at -$1.5 million in Q4 2025.
- Historically, Common Equity has averaged $5.4 million across 5 years, with a median of $4.6 million in 2025.
- Annual changes were most pronounced in 2024 — Common Equity soared 16563.04% — and 2026, when it slumped 125.82%.
- Vivos Therapeutics' Common Equity stood at $4.8 million in 2022, then sank by 91.44% to $411000.0 in 2023, then jumped by 1835.28% to $8.0 million in 2024, then slumped by 119.49% to -$1.5 million in 2025, then climbed by 26.58% to -$1.1 million in 2026.
- Business Quant data shows VVOS's Common Equity at -$1.1 million in Q1 2026, -$1.5 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | -3.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14 Mn |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 7.95 Mn |
| Sep 30, 2024 | 7.67 Mn |
| Jun 30, 2024 | 6.35 Mn |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 411,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 6.99 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Sep 30, 2022 | 9.86 Mn |
| Jun 30, 2022 | 14.84 Mn |
| Mar 31, 2022 | 21.04 Mn |
| Dec 31, 2021 | 25.54 Mn |
| Sep 30, 2021 | 32.47 Mn |
| Jun 30, 2021 | 36.48 Mn |